ASMB Latest Press Releases

-- November 2, 2026 --

Assembly Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 4:00 PM

-- October 29, 2026 --

Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus Globe Newswire 4:00 PM

-- October 5, 2026 --

Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting 2026 Globe Newswire 10:00 AM

-- September 10, 2026 --

Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference Globe Newswire 4:15 PM

-- September 8, 2026 --

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program Globe Newswire 4:00 PM

-- August 13, 2026 --

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates Globe Newswire 4:00 PM

Market Data Delayed 15 Minutes